Cancer and the microbiota
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
A host’s microbiota may increase, diminish, or have no effect at all on cancer susceptibility. Assigning causal roles in cancer to specific microbes and microbiotas, unraveling host-microbiota interactions with environmental factors in carcinogenesis, and exploiting such knowledge for cancer diagnosis and treatment are areas of intensive interest. This Review considers how microbes and the microbiota may amplify or mitigate carcinogenesis, responsiveness to cancer therapeutics, and cancer-associated complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss of microbial diversity (dysbiosis) is associated with chronic health conditions (26–28) and cancer (8–10), and is also associated with poor outcomes to certain forms of cancer therapy including allogeneic stem cell transplant (29).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“It has recently emerged that factors beyond tumor genomics influence cancer development and therapeutic responses (4–7), including host factors such as the gastrointestinal (gut) microbiome (8–10).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“their gene count that exceeds the human genome’s gene count by ~100-fold and enables diverse metabolic programming”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“the number of microbes that inhabit the human body (roughly equal to the number of human cells)”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“their effects on host immune system development and activity, including antitumor immunosurveillance (27–31).”
From The microbiome and human cancer (2021) · cites this paper as [31]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Self-citationMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Research works printed but not linked: 1
- 10.1111/j.1572-0241.2000.01860.x · doi:10.1111/j.1572-0241.2000.01860.x · Paper page
Cited by
Items 401–500 of 1,001
Chen, J., Li, T., Liang, J., Huang, Q., Huang, J., Ke, Y., & Sun, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112443 · Cited by 42
Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments
Vitorino, M. M., de Almeida, S. B., Costa, D. A., Faria, A., Calhau, C., & Braga, S. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.815772 · Cited by 47
“Gut microbiota is, as mentioned previously, an emerging field of research that is being associated with cancer through direct and indirect interference in diverse biological processes: host cell proliferation and death, immune system function, chronic inflammation, oncogenic signalling, hormonal and detoxification pat…”
BackgroundGut microbiota and its therapeutic implications in tumor microenvironment interactions
Feng, P., Xue, X., Bukhari, I., Qiu, C., Li, Y., Zheng, P., & Mi, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1287077 · Cited by 43
“Tumors located on boundary surfaces-including the oropharynx, skin, and the respiratory, digestive, and genitourinary tracts-contain microbiota, which complicates cancer-microbe causality (Garrett, 2015).”
BackgroundMolecular mechanistic pathway of colorectal carcinogenesis associated with intestinal microbiota
Mandal, P. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.12.008 · Cited by 47
Microbiota, Epithelium, Inflammation, and TGF-β Signaling: An Intricate Interaction in Oncogenesis
Pang, X., Tang, Y.-J., Ren, X., Chen, Q., Tang, Y., & Liang, X. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01353 · Cited by 39
Li, J., Lu, Y., Wang, D., Quan, F., Chen, X., Sun, R., Zhao, S., Yang, Z., Tao, W., Ding, D., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.059 · Cited by 39
Stem Cell Impairment at the Host-Microbiota Interface in Colorectal Cancer
Marzano, M., Fosso, B., Piancone, E., Defazio, G., Pesole, G., & Robertis, M. D. (2021) · Cancers · doi:10.3390/cancers13050996 · Cited by 41
“Tumor sites have impaired intestinal epithelial barriers that can further enhance carcinogenesis by allowing invading bacteria to penetrate the intestinal mucosa, resulting in increased inflammation [150].”
BackgroundInflammation and infection in plasma cell disorders: how pathogens shape the fate of patients
Caro, J., Braunstein, M. J., Williams, L. S., Bruno, B., Kaminetzky, D., Siegel, A., Razzo, B. M., Alfandari, S., Morgan, G. J., Davies, F. E., et al. (2022) · Leukemia · doi:10.1038/s41375-021-01506-9 · Cited by 41
“More recently, commensal bacteria in the gut are suspected to contribute to the development of extramucosal tumors, including MM [17].”
BackgroundChan, J. Y. K., Cheung, M. K., Lan, L., Ng, C. W. K., Lau, E. H. L., Yeung, Z. W. C., Wong, E. W. Y., Leung, L. L., Qu, X., Cai, L., et al. (2022) · Oral Oncology · doi:10.1016/j.oraloncology.2022.106245 · Cited by 43
The emerging role of bacterial extracellular vesicles in human cancers
Liang, A., Korani, L., Yeung, C. L. S., Tey, S. K., & Yam, J. W. P. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12521 · Cited by 45
“Currently, it is known that approximately 20% of human cancers are associated with the microbiome (Garrett, 2015).”
BackgroundInfluentialMaximizing the Utility of Cancer Transcriptomic Data
Xiang, Y., Ye, Y., Zhang, Z., & Han, L. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.09.009 · Cited by 40
Evaluating gut microbiota profiles from archived fecal samples
Rounge, T. B., Meisal, R., Nordby, J. I., Ambur, O. H., de Lange, T., & Hoff, G. S. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0896-6 · Cited by 42
Mass spectrometry-based fecal metabolome analysis
Xu, J., Zhang, Q., Zheng, J., Yuan, B., & Feng, Y. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.12.027 · Cited by 41
Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
Veigas, F., Mahmoud, Y. D., Merlo, J. P., Rinflerch, A., Rabinovich, G. A., & Girotti, M. R. (2021) · Cancers · doi:10.3390/cancers13051018 · Cited by 45
Mucins as anti-cancer targets: perspectives of the glycobiologist
Brockhausen, I., & Melamed, J. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-09986-8 · Cited by 44
Taguchi, K., Fukami, K., Elias, B. C., & Brooks, C. R. (2021) · Toxins · doi:10.3390/toxins13050361 · Cited by 40
“With better understanding as technology advances, gut microbiota seems to not only maintain homeostasis, but also to be involved in the pathology of several human diseases including obesity [19], hypertension [20], cancer [21], depression [22], and cardiovascular diseases [23].”
BackgroundCharacterization of the fecal microbiota in gastrointestinal cancer patients and healthy people
Li, N., Bai, C., 管远志, Zhao, L., Ge, Y., & Li, X. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02754-y · Cited by 40
The impact of microbiota on PD-1/PD-L1 inhibitor therapy outcomes: A focus on solid tumors
Najafi, S., Majidpoor, J., & Mortezaee, K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121138 · Cited by 38
Yin, B., Wang, X., Fang, Y., Li, Y., & Lu, P. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.899111 · Cited by 40
“Gut microbiota (Garrett, 2015; Rea et al., 2018) stimulates the production of ROS in tumor-infiltrating myeloid cells.”
BackgroundGut microbial response to host metabolic phenotypes
Hou, J., Xiang, J., Li, D., Liu, X., & Pan, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1019430 · Cited by 39
“Numerous studies have demonstrated that changes in the abundance of gut microbiota are a common marker of neoplastic diseases, such as Fusobacterium nucleatum, Escherichia coli, Bacteroides fragilis, and Aspergillus are associated with carcinogenesis (176, 177); By comparing the gut flora of gestational diabetes patie…”
BackgroundCervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer
Shen, J., Sun, H. X., Chu, J., Gong, X., & Liu, X. (2024) · Infectious Agents and Cancer · doi:10.1186/s13027-024-00573-8 · Cited by 52
“The dysregulated immune response can create appropriate microenvironment for persistent HPV infection [60] and tumor development [89, 126].”
BackgroundHuman intestinal microbiome: Role in health and disease
Cantón, R., Ramos, P. D. L., Botella, A. G., García‐Lledó, A., Hernández‐Sampelayo, T., Gómez‐Pavón, J., del Castillo, J. M. G., Martín-Delgado, M. C., Martín‐Sánchez, F. J., Martínez‐Sellés, M., et al. (2024) · Revista Española de Quimioterapia · doi:10.37201/req/056.2024 · Cited by 40
Side Effects and Complications of Proton Pump Inhibitors: A Pediatric Perspective
Stark, C. M., & Nylund, C. M. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.08.064 · Cited by 36
Organoids Provide an Important Window on Inflammation in Cancer
Baker, K. (2018) · Cancers · doi:10.3390/cancers10050151 · Cited by 41
Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer
Boutriq, S., González-González, A., Plaza-Andrades, I. J., Laborda-Illanes, A., Sánchez‐Alcoholado, L., Peralta-Linero, J., Domínguez-Recio, M. E., Bermejo-Pérez, M. J., Lavado-Valenzuela, R., Alba, E., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070659 · Cited by 44
“Notwithstanding, dysbiosis promotes the development of various diseases [33].”
BackgroundGlobal Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer
Wang, J., Wang, Y., Li, Z., Gao, X., & Huang, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.685641 · Cited by 41
“Numerous studies have identified links between the microbiota and tumorigenesis and progression in various cancer types (24, 25).”
BackgroundSingh, D., Khan, M. A., & Siddique, H. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120008 · Cited by 38
Chu, F., Li, Y., Meng, X., Li, Y., Li, T., Zhai, M., Zheng, H., Xin, T., Su, Z., Lin, J., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.733979 · Cited by 41
“Increasing evidence has shown that alterations in gut microbiota are potentially linked to inflammation and cancer (Schwabe and Jobin, 2013; Abreu and Peek, 2014; Garrett, 2015; Vogtmann and Goedert, 2016; Bhatt et al., 2017).”
BackgroundZhu, J. L., Li, M., Shao, D., Ma, S., & Wei, W. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.757139 · Cited by 40
“Once the microbiota becomes unbalanced, alteration may occur to the microenvironment and then lead to gastrointestinal diseases and even cancer (6, 7).”
BackgroundCFTR and Gastrointestinal Cancers: An Update
Bhattacharya, R., Blankenheim, Z., Scott, P. M., & Cormier, R. T. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060868 · Cited by 39
“Microbial dysbiosis is also a common feature in CRC [100], thus CF-related dysbiosis may play an important role in susceptibility to CRC [101].”
BackgroundThe role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xue, X., Li, R., Chen, Z., Li, G., Liu, B., Guo, S., Yue, Q., Yang, S., Xie, L., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235827 · Cited by 39
Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions
Martinez-Martín, N. (2017) · Journal of Immunology Research · doi:10.1155/2017/2197615 · Cited by 36
Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
Haque, S., Raina, R., Afroze, N., Hussain, A., Alsulimani, A., Singh, V., Mishra, B. N., Kaul, S., & Kharwar, R. N. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.024 · Cited by 37
Characterization of the oral and gut microbiome in children with obesity aged 3 to 5 years
Ma, T., Wu, Z., Lin, J., Shan, C., Abasijiang, A., & Zhao, J. F. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1102650 · Cited by 45
“The oral cavity is the point of entry for many pathogens, and this cavity is closely related to the human microbiota (Irrazábal et al., 2014; Said et al., 2014; Garrett, 2015).”
BackgroundJi, J. H., Ha, S. Y., Lee, D., Sankar, K. N., Koltsova, E. K., Abou‐Alfa, G. K., & Yang, J. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087640 · Cited by 38
Pan, Z., Wu, N., & Jin, C. (2023) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2023/3080969 · Cited by 42
“Dysbiosis of the intestinal microbiota and intestinal mucosal immune damage are closely related to the occurrence and development of many diseases, such as tumors, cardiovascular diseases, viral infections, and immune diseases [14–18].”
Gut microbiota in patients with prostate cancer: a systematic review and meta-analysis
Huang, H., Liu, Y., Zhi, W., Chen, C., Wang, C., Li, H., & Yang, X. (2024) · BMC Cancer · doi:10.1186/s12885-024-12018-x · Cited by 46
Intratumoral levels and prognostic significance of Fusobacterium nucleatum in cervical carcinoma
Huang, S., Chen, J., Lian, L.-Y., Cai, H., Zeng, H.-S., Zheng, M., & Liu, M. (2020) · Aging · doi:10.18632/aging.104188 · Cited by 53
“Such transformations are exemplified by the uses of bacteria in the field of industrial biotransformation in which various taxa are used to chemically modify non-biological organic molecules and thereby modulate their degradation [11, 12].”
BackgroundSITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
Hu‐Lieskovan, S., Bhaumik, S., Dhodapkar, K. M., Grivel, J., Gupta, S. V., Hanks, B. A., Janetzki, S., Kleen, T. O., Koguchi, Y., Lund, A. W., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000705 · Cited by 40
Sepich‐Poore, G. D., Guccione, C., Laplane, L., Pradeu, T., Curtius, K., & Knight, R. (2022) · BioEssays · doi:10.1002/bies.202100252 · Cited by 33
Hospital Readmissions in Patients With Carbapenem-ResistantKlebsiella pneumoniae
Messina, J. A., Cober, E., Richter, S. S., Pérez, F., Salata, R. A., Kalayjian, R. C., Watkins, R., Scalera, N. M., Doi, Y., Kaye, K. S., et al. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.298 · Cited by 35
The intestinal microbiome and surgical disease
Krezalek, M. A., Skowron, K. B., Guyton, K. L., Shakhsheer, B. A., Hyoju, S. K., & Alverdy, J. C. (2016) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2016.06.001 · Cited by 38
Sun, J. G., Huang, T., Chen, C., Cao, T.-T., Cheng, K., Liao, X.-P., & Liu, Y.-H. (2017) · Scientific Reports · doi:10.1038/s41598-017-04672-y · Cited by 39
Yang, W., Petersen, C., Pees, B., Zimmermann, J., Waschina, S., Dirksen, P., Rosenstiel, P. C., Tholey, A., Leippe, M., Dierking, K., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01793 · Cited by 41
“, 2013), liver cirrhosis (Abu-Shanab and Quigley, 2010), and even cancer (Garrett, 2015).”
BackgroundDiet, Microbiota, and Colorectal Cancer
Grazioso, T. P., Brandt, M., & Djouder, N. (2019) · iScience · doi:10.1016/j.isci.2019.10.011 · Cited by 39
“Although the presence of bacteria usually occurs in a symbiotic background, accumulated evidence has linked bacterial contribution in carcinogenesis (Garrett, 2015), and therefore, dysbiosis due tomicrobiota dysregulation might trigger the malignant transformations of colon cells.”
BackgroundGut microbiota; an overlooked effect of phosphate binders
Saadat, Y. R., Niknafs, B., Khatibi, S. M. H., Ardalan, M., Majdi, H. S., Bahmanpoor, Z., Abediazar, S., & Vahed, S. Z. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172892 · Cited by 38
Emerging role of microbiota in immunomodulation and cancer immunotherapy
Singh, R. P., Bashir, H., & Kumar, R. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.008 · Cited by 35
Kumpitsch, C., Moissl‐Eichinger, C., Pock, J., Thurnher, D., & Wolf, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-73515-0 · Cited by 33
Alterations in mucosa-associated microbiota in the stomach of patients with gastric cancer
Deng, Y., Ding, X., Song, Q., Zhao, G., Han, L., Ding, B., Wang, X., Hao, X., & Li, H. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00596-y · Cited by 40
Zhao, L., Zhang, X., Zuo, T., & Yu, J. Q. (2017) · Engineering · doi:10.1016/j.eng.2017.01.012 · Cited by 36
Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions
Polimeno, L., Barone, M., Mosca, A., Viggiani, M. T., Joukar, F., Mansour‐Ghanaei, F., Mavaddati, S., Daniele, A., Debellis, L., Bilancia, M., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8040469 · Cited by 37
The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M
Sun, J., Xia, Q., Zhong, X.-Y., Liu, Z., & Wang, S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1182322 · Cited by 34
“The microbiota has been found to be associated with a variety of cancers (Garrett, 2015) and, in particular, the gut microbiome exerts significant roles in local and distant tumorigenesis (Li et al., 2019; Si et al., 2021).”
BackgroundNorenhag, J., Edfeldt, G., Stålberg, K., García, F. R., Hugerth, L. W., Engstrand, L. G., Fransson, E., Du, J., Schuppe‐Koistinen, I., & Olovsson, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-61942-2 · Cited by 41
Zhang, S., Peng, L., Goswami, S., Li, Y., Dang, H., Xing, S., Feng, P., Nigro, G., Liu, Y., Ma, Y., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01937-5 · Cited by 37
Therapy-induced microenvironmental changes in cancer
Ma, Y., Yang, H., Pitt, J. M., Kroemer, G., & Zitvogel, L. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1401-8 · Cited by 35
Case for a role of the microbiome in gynecologic cancers: Clinician's perspective
Mert, İ., Walther-Antonio, M. R. S., & Mariani, A. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13701 · Cited by 33
Role of Microbiome in Modulating Immune Responses in Cancer
Bose, M., & Mukherjee, P. (2019) · Mediators of Inflammation · doi:10.1155/2019/4107917 · Cited by 35
“For example, data from germfree and antibiotic-treated mice show a markedly reduced response to CpG stimulation in the setting of cancer immunotherapy [66].”
BackgroundTargeting virulence factors as an antimicrobial approach: Pigment inhibitors
Ni, S., Li, B., Xu, Y., Mao, F., Li, X., Lan, L., Zhu, J., & Li, J. (2019) · Medicinal Research Reviews · doi:10.1002/med.21621 · Cited by 34
Tumour associated glycans: A route to boost immunotherapy?
Scott, E., Elliott, D. J., & Munkley, J. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.015 · Cited by 31
A metagenomic study of biliary microbiome change along the cholecystitis‐carcinoma sequence
Song, X., Wang, X., Hu, Y., Li, H., Ren, T., Li, Y., Liu, L., Li, L., Li, X., Wang, Z., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.97 · Cited by 34
Roles of Microbiota in Cancer: From Tumor Development to Treatment
Bagheri, Z., Moeinzadeh, L., & Razmkhah, M. (2022) · Journal of Oncology · doi:10.1155/2022/3845104 · Cited by 35
Burcher, K. M., Burcher, J. T., Inscore, L., Bloomer, C. H., Furdui, C. M., & Porosnicu, M. (2022) · Cancers · doi:10.3390/cancers14174116 · Cited by 37
“An emerging facet of research involves delving into the possibility that oral microbes may serve as potential biomarkers for various malignancies and pre-malignant lesions [35].”
BackgroundInfluentialMalcomson, F. C., & Mathers, J. C. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102710 · Cited by 37
“of people colonised by such bacteria develop cancer because of the complex interactions between host and microbial genotypes that influence individual susceptibility [75].”
BackgroundSeven facts and five initiatives for gut microbiome research
Li, D., Gao, C., Zhang, F., Yang, R., Lan, C., Ma, Y., & Wang, J. (2020) · Protein & Cell · doi:10.1007/s13238-020-00697-8 · Cited by 37
“…fatty liver diseases (Canfora et al., 2019), cardiovascular diseases (Schiattarella et al., 2017), autoimmune and inflammatory diseases (Clemente et al., 2018), psychological and neurological disorders (Cryan et al., 2020), and cancer (Garrett, 2015; Yu and Schwabe, 2017; Vitiello et al., 2019).”
BackgroundUrobiome in Gender—Related Diversities of Bladder Cancer
Bilski, K., Dobruch, J. T., Kozikowski, M., Skrzypczyk, M., Oszczudłowski, M., & Ostrowski, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124488 · Cited by 33
“It has been estimated that microbiota may be associated with more than 20% of malignancies [35], but the role of only few microorganisms as carcinogens is widely known and well established.”
BackgroundDong, S., Li, W., Li, X., Wang, Z., Zhou, C., Shi, H., He, R., Chen, C., & Zhou, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1038650 · Cited by 38
“Initially, it had been postulated that microbial changes have insignificant effects on tumour susceptibility, especially PC, and that tweaking the microbiome structure or composition does not affect the poor prognosis of PC patients (170).”
BackgroundThe Urinary Microbiome and Bladder Cancer
Heidar, N. F. A., Bhat, T. A., Shabir, U., & Hussein, A. A. (2023) · Life · doi:10.3390/life13030812 · Cited by 35
“coli has been known to produce the genotoxin colibactin, which leads to DNA damage in colorectal cancer [48].”
BackgroundThe Endometrial Microbiota: Challenges and Prospects
Bwanga, P. K., Tremblay-Lemoine, P.-L., Timmermans, M., Ravet, S., Munaut, C., Nisolle, M., & Henry, L. (2023) · Medicina · doi:10.3390/medicina59091540 · Cited by 39
“The microbiota via its altered state, called dysbiosis, is suspected to promote carcinogenesis by altering the host immune defense responses [51], shifting the balance between cell proliferation and death and influencing the metabolism of self-produced factors, ingested molecules and drugs [52,53].”
BackgroundBacterial infection and microbiota in carcinogenesis and tumor development
Li, Q. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1294082 · Cited by 34
“Researches have investigated the relationship between microbiota and cancer in multiple solid tumors (Zhao et al., 2021) (Garrett, 2015).”
BackgroundGut Microbiome–Colorectal Cancer Relationship
Yadav, D., Sainatham, C., Filippov, E., Kanagala, S. G., Ishaq, S. M., & Jayakrishnan, T. (2024) · Microorganisms · doi:10.3390/microorganisms12030484 · Cited by 40
“Dysbiosis is associated with cancer and poor outcomes in certain forms of cancer therapy, including allogenic stem cell transplantation [110–113].”
BackgroundLiao, K., Wen, J., Liu, Z., Zhang, B., Zhang, X., Fu, Y., Zhang, W., Hu, H., Ai, K., Zhu, W., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102820 · Cited by 40
Kohlhapp, F. J., Huelsmann, E. J., Lacek, A. T., Schenkel, J. M., Lusciks, J., Broucek, J. R., Goldufsky, J. W., Hughes, T. M., Zayas, J. P., Dolubizno, H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.068 · Cited by 36
Ren, X., Zhu, Y., Gamallat, Y., Ma, S., Chiwala, G., Meyiah, A., & Xin, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.123 · Cited by 32
Gut Microbiota Alteration After Long-Term Consumption of Probiotics in the Elderly
Gao, R., Zhang, X., Huang, L., Shen, R., & Qin, H. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9403-1 · Cited by 33
Evaluation of cancer risk in patients with periodontal diseases
Güven, D. C., Dızdar, Ö., Akman, A. C., Berker, E., Yekedüz, E., Ceylan, F., Başpınar, B., Akbıyık, İ., Aktaş, B. Y., Yüce, D., et al. (2019) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1812-8 · Cited by 37
Scherr, A., Jassowicz, A., Pató, A., Elßner, C., Ismail, L., Schmitt, N., Hoffmeister‐Wittmann, P., Neukirch, L., Gdynia, G., Goeppert, B. F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031099 · Cited by 36
“Additionally, a recent report discovered a major role of the central autophagy protein Atg7 in the prevention of dysbiosis-induced colorectal tumorigenesis [13,23].”
BackgroundExploiting the obesity-associated immune microenvironment for cancer therapeutics
Desharnais, L., Walsh, L. A., & Quail, D. F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107923 · Cited by 31
Borgognone, A., Serna, G., Noguera-Julián, M., Alonso, L., Parera, M., Català‐Moll, F., Sanchez, L. R., Fasani, R., Paredes, R., & Nuciforo, P. G. (2021) · Cancers · doi:10.3390/cancers13215421 · Cited by 35
“Several mechanistic studies have hypothesized that the close interaction of diverse microbial communities with host intestinal cells and immune system may induce alterations in the metabolic environment, thus directly or indirectly influencing mutagenesis rate and tumor progression [7].”
BackgroundEnsDeepDP: An Ensemble Deep Learning Approach for Disease Prediction Through Metagenomics
Shen, Y., Zhu, J., Deng, Z., Lu, W., & Wang, H. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3201295 · Cited by 34
“As the matter of fact, growing evidence has shown that dysbiosis shifts in human microbiome composition can be strongly associated with a wide range of diseases like inflammatory bowel disease (IBD) [4], obesity[5], diabetes [6], cirrhosis[7], colorectal cancer (CRC) [8], and others[9].”
BackgroundImpact of intestinal dysbiosis on breast cancer metastasis and progression
Zhang, J., Xie, Q., Huo, X., Liu, Z., Da, M., Yuan, M., Zhao, Y. D., & Shen, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1037831 · Cited by 35
“4 Genomic stability and DNA damage DNA damage may not be sufficient to promote cancer development, but microbes can trigger transformation by destabilizing genes, cell proliferation and death, and it has been demonstrated that microbes cause cancer development by damaging host DNA in order to survive (135).”
BackgroundManilla, V., Tommaso, N. D., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Microorganisms · doi:10.3390/microorganisms11020267 · Cited by 32
“ME also increases reactive oxygen species (ROS) formation and DNA damage, favoring tumorigenesis process [50,51].”
BackgroundIn pursuit of cancer metastasis therapy by bacteria and its biofilms: History or future
Adnan, M., Khan, S. A., Al-Shammari, E., Patel, M. B., Saeed, M., & Hadi, S. S. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.01.018 · Cited by 31
Linking the Gut Microbiota to Bone Health in Anorexia Nervosa
Strock, N. C. A., Koltun, K. J., VanEvery, H., Rogers, C. J., & Souza, M. J. D. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0420-5 · Cited by 33
Li, Y., Liu, G., Gong, R., & Xi, Y. (2023) · Current Microbiology · doi:10.1007/s00284-023-03361-6 · Cited by 36
Influence of Microbiota on Tumor Immunotherapy
Yu, X., Li, W., Li, Z., Wu, Q., & Sun, S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91771 · Cited by 37
“For instance, this phenomenon may develop from the microbial activation of NF-κB, a pivotal regulatory factor in cancer-associated inflammation [246,251, 252].”
BackgroundExploring the gut microbiome’s role in colorectal cancer: diagnostic and prognostic implications
Chen, G., Ren, Q., Zhong, Z., Li, Q., Huang, Z., Zhang, C., Yuan, H., Feng, Z., Chen, B., Wang, N., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1431747 · Cited by 40
“There is mounting evidence to suggest that the gut microbiota plays a crucial role in the initiation, progression, and metastasis of CRC (8 – 10).”
BackgroundInsights into the role of the intestinal microbiota in colon cancer
Oke, S., & Martín, A. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17694832 · Cited by 38
Rastogi, Y. R., Saini, A. K., Thakur, V. K., & Saini, R. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093212 · Cited by 35
Microbiome and pancreatic ductal adenocarcinoma
Tijeras‐Raballand, A., Hilmi, M., Astorgues‐Xerri, L., Nicolle, R., Bièche, I., & Neuzillet, C. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2020.101589 · Cited by 32
The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis
Rajasekaran, K., Carey, R. M., Lin, X., Seckar, T. D., Wei, Z., Chorath, K. T., Newman, J. G., O'Malley, B. W., Weinstein, G. S., Feldman, M. D., et al. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105305 · Cited by 31
Application of third-generation sequencing in cancer research
Chen, Z., & He, X. (2021) · Medical Review · doi:10.1515/mr-2021-0013 · Cited by 37
Impact of gastrointestinal surgery upon the gut microbiome: A systematic review
Tarazi, M., Jamel, S., Mullish, B. H., Markar, S. R., & Hanna, G. B. (2021) · Surgery · doi:10.1016/j.surg.2021.10.014 · Cited by 31
A New Comorbidity in Periodontitis: Fusobacterium nucleatum and Colorectal Cancer
Mesa, F., Mesa-López, M. J., VALENZUELA, J. E., Benavides‐Reyes, C., Nibali, L., Ide, M., Mainas, G., Rizzo, M., & Magán‐Fernández, A. (2022) · Medicina · doi:10.3390/medicina58040546 · Cited by 37
“Lately, scientific evidence has increased with respect to the human bowel microbiome as a key factor that influences the development, progression, and response to treatment of CRC [27,28].”
BackgroundBrewster, W. R., Burkett, W. C., Ko, E. M., Bae-Jump, V. L., McCoy, A. N., & Keku, T. O. (2022) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2022.101017 · Cited by 35
“Microbes and the microbiota may contribute to carcinogenesis by altering the balance of proliferation and death of the host cell, perturbating immune system function, and influencing metabolism within the host (Garrett, 2015).”
BackgroundIntratumoral microbiota: new frontiers in tumor immunity
Zhang, Z., Liao, Y., & Tang, D. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac063 · Cited by 32
Villar, S. S., Vásquez-Domínguez, E., Pérez-Molina, J. A., Sainz, T., de Benito, A., Latorre, A., Moyá, A., Gosalbes, M. J., & Moreno, S. (2016) · AIDS · doi:10.1097/qad.0000000000001352 · Cited by 31
Periodontal pathogens and cancer development
Zhou, Y., Meyle, J., & Groeger, S. E. (2024) · Periodontology 2000 · doi:10.1111/prd.12590 · Cited by 43
Wang, L., Wang, Y., Chen, A. B., Teli, M., Kondo, R., Jalali, A., Fan, Y., Liu, S., Zhao, X., Siegel, A. P., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901388r · Cited by 30
Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway
Lu, P., Xu, M., Xiong, Z., Zhou, F., & Wang, L. (2019) · Cancer Management and Research · doi:10.2147/cmar.s185766 · Cited by 32
Gut Microbiota and Cancer of the Host: Colliding Interests
Baffy, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_5 · Cited by 32
Metadata
- Authors
- Garrett, W. S.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- ORCID
- Garrett, Wendy S.
- Venue
- Science
- Published
- 2015-04-03
- Volume
- 348
- Issue
- 6230
- Pages
- 80-86
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5535753
- OpenAlex
- W2073924079
- Cited by
- 1,404
- References
- 119
- Citations by year
- 2026: 145 · 2025: 169 · 2024: 169 · 2023: 151 · 2022: 162 · 2021: 141 · 2020: 127 · 2019: 106 · 2018: 77 · 2017: 68 · 2016: 58 · 2015: 29
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01CA154426)
- Burroughs Wellcome Career in Medical Sciences Award
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- gut microbiota, cancer susceptibility, carcinogenesis, host-microbe interactions, cancer therapy response, cancer diagnosis
- MeSH terms
- Humans, Immunotherapy, Neoplasms, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.